A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer

被引:52
作者
Assenholt, Marianne S. [2 ]
Petersen, Jorgen B. [2 ]
Nielsen, Soren K. [2 ]
Lindegaard, Jacob C. [1 ]
Tanderup, Kari [1 ]
机构
[1] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Med Phys, DK-8000 Aarhus, Denmark
关键词
D O I
10.1080/02841860802266698
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. Locally advanced cervical cancer is usually treated with external beam radiotherapy followed by brachytherapy (BT). However, if response or tumour topography is unfavourable it may be difficult to reach a sufficient BT dose. The purpose of this study was to explore whether an applicator guided stereotactic IMRT boost could be combined with brachytherapy to improve dose volume parameters. Material and methods. Dose plans of 6 patients with HR CTV volumes of 31-100cc at the time of BT were analysed. MRI was performed with a combined intracavitary (IC)-interstitial (IS) ring applicator in situ. A radiotherapy schedule consisting of 45Gy (1.8Gy x 25) IMRT followed by boost of 28Gy (7Gy x 4fx) was modelled. Four different boost techniques were evaluated: IC-BT, IC/IS-BT, IC-BT+IMRT and IMRT. Dose plans were optimised for maximal tumour dose (D90) and coverage (V85Gy) while respecting DVH constraints in organs at risk: D2cc < 75Gy in rectum and sigmoid and < 90Gy in bladder (EQD2). In combined BT+IMRT dose plans, the IMRT plan was optimised on top of the BT dose distribution. Volumes irradiated to more than 60 Gy EQD2 (V60Gy) were evaluated. Results. Median dose coverage in IC plans was 74% [66-93%]. By using IC/IS or IC-BT+IMRT boost, the median coverage was improved to 95% [78-99%], and to 96% [69-99%] respectively. For IMRT alone, a median coverage of 98% [90-100%] was achieved, but V60Gy volumes were significantly increased by a median factor of 2.0 [1.4-2.3] as compared to IC/IS. It depended on the individual tumour topography whether IC/IS-BT or IC-BT+IMRT boost was the most favourable technique. Conclusion. It is technically possible to create dose plans that combine image guided BT and IMRT. In this study the dose coverage could be significantly increased by adding IS-BT or IMRT boost to the intracavitary dose. Using IMRT alone for boost cannot be advocated since this results in a significant increase of the volume irradiated to 60Gy.
引用
收藏
页码:1337 / 1343
页数:7
相关论文
共 19 条
[1]   A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients [J].
Aydogan, Bulent ;
Mundt, Arno J. ;
Smith, Brett D. ;
Mell, Loren K. ;
Wang, Steve ;
Sutton, Harold ;
Roeske, John C. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01) :266-273
[2]   Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies [J].
Barillot, I ;
Horiot, JC ;
Maingon, P ;
Truc, G ;
Chaplain, G ;
Comte, J ;
Brenier, JP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :189-200
[3]  
DEBRABANDERE M, 2007, RADIOTHER ONCOL
[4]   The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:: Clinical feasibility and preliminary results [J].
Dimopoulos, Johannes C. A. ;
Kirisits, Christian ;
Petric, Primoz ;
Georg, Petra ;
Lang, Stefan ;
Berger, Daniel ;
Poetter, Richard .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01) :83-90
[5]  
Georg D, 2008, INT J RAD ONCOL BIOL
[6]   Preliminary results of a comparison between high-tech external beam and high-tech brachytherapy for cervix carcinoma [J].
Georg, Dietmar ;
Kirisits, Christian ;
Hillbrand, Martin ;
Dimopoulos, Johannes ;
Poetter, Richard .
STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (Suppl 2) :19-20
[7]   Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: Radiobiological and dosimetric considerations [J].
Guerrero, M ;
Li, XA ;
Ma, LJ ;
Linder, J ;
Deyoung, C ;
Erickson, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03) :933-939
[8]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV [J].
Haie-Meder, C ;
Pötter, R ;
Van Limbergen, E ;
Briot, E ;
De Brabandere, M ;
Dimopoulos, J ;
Dumas, I ;
Hellebust, TP ;
Kirisits, C ;
Lang, SF ;
Muschitz, S ;
Nevinson, J ;
Nulens, A ;
Petrow, P ;
Wachter-Gerstner, N .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :235-245
[9]   Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging [J].
Hatano, K ;
Sekiya, Y ;
Araki, H ;
Sakai, M ;
Togawa, T ;
Narita, Y ;
Akiyama, Y ;
Kimura, S ;
Ito, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (03) :639-644
[10]   The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:: Design, application, treatment planning, and dosimetric results [J].
Kirisits, C ;
Lang, S ;
Dimopoulos, J ;
Berger, D ;
Georg, D ;
Pötter, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (02) :624-630